Dan Rudin

BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A

Barbara A. Konkle, Amy D. Shapiro, Doris Quon et al. · New England Journal of Medicine · 2020 · 126 citations · Full text

Good physicians from the perspective of their patients

Ami Schattner, Dan Rudin, Navah Jellin · BMC Health Services Research · 2004 · 97 citations · Full text

A randomized phase 1 pharmacokinetic trial comparing the potential biosimilar<scp>PF</scp>‐05280014 with trastuzumab in healthy volunteers (<scp>REFLECTIONS B</scp>327‐01)

Donghua Yin, Kerry Barker, Ruifeng Li et al. · British Journal of Clinical Pharmacology · 2014 · 73 citations · Full text

Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study

Beatrice Nolan, Johnny Mahlangu, Ingrid Pabinger et al. · Haemophilia · 2020 · 72 citations · Full text

Long‐term safety and sustained efficacy for up to 5 years of treatment with recombinant factor IX Fc fusion protein in subjects with haemophilia B: Results from the B‐YOND extension study

John Pasi, Kathelijn Fischer, Margaret V. Ragni et al. · Haemophilia · 2020 · 44 citations · Full text